Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Product List of all Active Pharmaceutical Ingredients (APIs) supplied/manufactured by Mylan Inc

    Client Virtual Booth

    MYLAN INC

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Viatris
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Robert J. Coury Global Center 1000 Mylan Blvd. Canonsburg, PA 15317
    Telephone
    Telephone
    +1.724.514.1800
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.viatris.com/en
    Linkedin
    Linkedin
    https://www.linkedin.com/company/viatris/
    Twitter
    Twitter
    https://twitter.com/viatrisinc

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    left grey arrow
    right gray arrow
    ListList of Products
    Full View ScreenFull Screen View
    refresh Reset Filter
    refresh Reset Filter
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Lamivudine

    PDF Supplier PDF
    URL Supplier Web Content
    See all info for this product

    See Less

    USDMF

    Found USDMF

    17750
    Active
    LAMIVUDINE USP
    2004-10-08
    CEP/COS

    Found CEP/COS

    R1-CEP 2014-034 - Rev 02
    Valid
    Lamivudine, SVL Process
    2022-08-30
    Japanese DMF

    Close JDMF

    Written Confirmation

    Found WC

    Indian CDSCO WC-0189n
    Valid
    Lamivudine EP
    2022-06-08
    Application Number
    17750
    R1-CEP 2014-034 - Rev 02
    Indian CDSCO WC-0189n
    Status
    Active
    Fees Paid
    Reviewed
    Valid
     
    Valid
    2025-07-25
    Filing Details
    LAMIVUDINE USP
    Lamivudine, SVL Process
    Lamivudine EP
    Issue/Submission Date
    2004-10-08
    2022-08-30
    2022-06-08
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Lamivudine

    PDF Supplier PDF
    URL Supplier Web Content
    See all info for this product

    See Less

    USDMF

    Found USDMF

    23431
    Active
    LAMIVUDINE USP (LVD)
    2010-01-06
    CEP/COS

    Caution CEP/COS

    R1-CEP 2011-044 - Rev 01
    Withdrawn by Holder
    Lamivudine
    2017-10-25
    Japanese DMF

    Close JDMF

    Written Confirmation

    Caution WC

    Indian CDSCO WC-0118
    Expired
    Lamivudine (Ph. Eur.)
    2019-08-05
    Application Number
    23431
    R1-CEP 2011-044 - Rev 01
    Indian CDSCO WC-0118
    Status
    Active
    Fees Paid
    N/A
    Withdrawn by Holder
     
    Expired
    2022-08-04
    Filing Details
    LAMIVUDINE USP (LVD)
    Lamivudine
    Lamivudine (Ph. Eur.)
    Issue/Submission Date
    2010-01-06
    2017-10-25
    2019-08-05
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Lamivudine

    PDF Supplier PDF
    URL Supplier Web Content
    See all info for this product

    See Less

    USDMF

    Found USDMF

    29613
    Active
    LAMIVUDINE USP (PROCESS-II)
    2015-09-01
    CEP/COS

    Close CEP/COS

    Japanese DMF

    Close JDMF

    Written Confirmation

    Caution WC

    Indian CDSCO WC-0189
    Expired
    Lamivudine (Ph. Eur.)
    2019-07-26
    Application Number
    29613
    Indian CDSCO WC-0189
    Status
    Active
    Fees Paid
    Reviewed
     
    Expired
    2022-07-26
    Filing Details
    LAMIVUDINE USP (PROCESS-II)
    Lamivudine (Ph. Eur.)
    Issue/Submission Date
    2015-09-01
    2019-07-26
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Lamivudine

    PDF Supplier PDF
    URL Supplier Web Content
    See all info for this product

    See Less

    USDMF

    Close USDMF

    CEP/COS

    Close CEP/COS

    Japanese DMF

    Close JDMF

    Written Confirmation

    Caution WC

    Indian CDSCO WC-0015
    Expired
    Lamivudine (USP/Ph. Eur)
    2019-06-03
    Application Number
    Indian CDSCO WC-0015
    Status
     
    Expired
    2022-06-02
    Filing Details
    Lamivudine (USP/Ph. Eur)
    Issue/Submission Date
    2019-06-03
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search